Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer-Reference-Cited by-同舟云学术

Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer

Published:2018-03-03 Issue:5 Volume:81 Page:815-821
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Yamada Suguru,Fujii Tsutomu,Yokoyama Yukihiro,Kawashima Hiroki,Maeda Osamu,Suzuki Kojiro,Okada Tohru,Ono Eizaburo,Yamaguchi Junpei,Takano Nao,Takami Hideki,Hayashi Masamichi,Niwa Yukiko,Hirooka Yoshiki,Ito Yoshiyuki,Naganawa Shinji,Ando Yuichi,Nagino Masato,Goto Hidemi,Kodera Yasuhiro

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-018-3554-3/fulltext.html

Reference24 articles.

1. Egawa S, Toma H, Ohigashi H, Okusaka T, Nakao A, Hatori T et al (2012) Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas 41(7):985–992

2. Von Hoff DD, Ramanathan RK, Borad MJ, Laheru DA, Smith LS, Wood TE et al (2011) Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J Clin Oncol 29(34):4548–4554

3. Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M et al (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369(18):1691–1703

4. Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364(19):1817–1825

5. Network NCC (2017) National Comprehensive Cancer Network NCCN clinical practice guidelines in oncology (NCCN Guidelines)

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer;Biomedicines;2024-07-18

2. “Conversion surgery” for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology (IAP) & Japan Pancreas Society (JPS) 2022;Pancreatology;2023-09

3. Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial;Nature Communications;2023-08-14

4. Comparative Effectiveness of FOLFIRINOX Versus Gemcitabine and Nab-paclitaxel in Initially Unresectable Locally Advanced Pancreatic Cancer: A Population-based Study to Assess Subsequent Surgical Resection and Overall Survival;Clinical Oncology;2023-05

5. High Intensity Focused Ultrasound Ablation for Patients With Locally Advanced Pancreatic Adenocarcinoma: A Propensity Score‐Matching Analysis;Journal of Ultrasound in Medicine;2023-01-24